NDC 16729-151
topotecan hydrochloride
Topotecan Hydrochloride
topotecan hydrochloride is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare, Inc.. The primary component is Topotecan Hydrochloride.
| Product ID | 16729-151_256208d7-142f-6105-e054-00144ff88e88 |
| NDC | 16729-151 |
| Product Type | Human Prescription Drug |
| Proprietary Name | topotecan hydrochloride |
| Generic Name | Topotecan Hydrochloride |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2013-07-23 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202351 |
| Labeler Name | Accord Healthcare, Inc. |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Active Ingredient Strength | 4 mg/4mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |